These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer? Vesely DL Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258 [TBL] [Abstract][Full Text] [Related]
7. The role of C-type natriuretic peptide in cardiovascular medicine. Kalra PR; Anker SD; Struthers AD; Coats AJ Eur Heart J; 2001 Jun; 22(12):997-1007. PubMed ID: 11428835 [No Abstract] [Full Text] [Related]
8. Acute hemodynamic effects of atrial natriuretic peptide in essential hypertension. Volpe M; De Luca N; Indolfi C; Mele AF; Rivera MP; Condorelli M; Trimarco B Kidney Int Suppl; 1988 Sep; 25():S83-5. PubMed ID: 2972868 [No Abstract] [Full Text] [Related]
9. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247 [TBL] [Abstract][Full Text] [Related]
10. Membrane-bound guanylate cyclase as the receptor of natriuretic peptides. A minireview. Rambotti MG; Spreca A; Donato R Ital J Anat Embryol; 1995; 100 Suppl 1():55-62. PubMed ID: 11322335 [TBL] [Abstract][Full Text] [Related]
11. [Atrial natriuretic peptides. The function of the atrial natriuretic peptide as hormone and neuropeptide]. Nakao K; Itoh H; Saito Y; Yamada T; Morii N; Sugawara A; Shiono S; Mukoyama M; Arai H; Hosoda K Nihon Rinsho; 1987 Nov; 45(11):2581-90. PubMed ID: 2965264 [No Abstract] [Full Text] [Related]
12. [Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide]. Feng HS; Zang YM; Zhu MZ; Pei JM; Wang YM; Wang L; Shi PT Sheng Li Xue Bao; 1999 Oct; 51(5):515-20. PubMed ID: 11498948 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of inhibitory effects of three natriuretic peptides on the proliferation of pulmonary artery smooth muscle cells of rats]. Dong MQ; Zhu MZ; Yu J; Shang LJ; Feng HS Sheng Li Xue Bao; 2000 Jun; 52(3):252-4. PubMed ID: 11956575 [TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system. Sabbatini ME Regul Pept; 2009 Apr; 154(1-3):5-15. PubMed ID: 19233231 [TBL] [Abstract][Full Text] [Related]
15. Do natriuretic peptides modify arterial baroreflexes in sheep? Thomas CJ; Woods RL Exp Physiol; 2004 Nov; 89(6):709-15. PubMed ID: 15364878 [TBL] [Abstract][Full Text] [Related]
16. N-terminal pro A-type natriuretic peptide but not N-terminal pro C-type natriuretic peptide concentrations are related to cardiac diseases in infants. Hammerer-Lercher A; Puschendorf B; Sommer R; Mair J; Tulzer G; Lechner E; Hawa G; Maitzen S; Woloszczuk W Clin Chim Acta; 2008 May; 391(1-2):118-9. PubMed ID: 18280250 [No Abstract] [Full Text] [Related]
18. Inhibitory effect of C-type natriuretic peptide on spontaneous contraction in gastric antral circular smooth muscle of rat. Guo HS; Cui X; Cui YG; Kim SZ; Cho KW; Li ZL; Xu WX Acta Pharmacol Sin; 2003 Oct; 24(10):1021-6. PubMed ID: 14531946 [TBL] [Abstract][Full Text] [Related]
19. Reversible pegylation prolongs the hypotensive effect of atrial natriuretic peptide. Nesher M; Vachutinsky Y; Fridkin G; Schwarz Y; Sasson K; Fridkin M; Shechter Y; Lichtstein D Bioconjug Chem; 2008 Jan; 19(1):342-8. PubMed ID: 18069777 [TBL] [Abstract][Full Text] [Related]
20. Dendroaspis natriuretic peptide and its functions in pig ovarian granulosa cells. Piao FL; Park SH; Han JH; Cao C; Kim SZ; Kim SH Regul Pept; 2004 May; 118(3):193-8. PubMed ID: 15003836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]